Indian pharmaceutical company Zydus has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world's third worst-hit nation. In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India. ZyCoV-D, its ...
READ MORE +